Position in DMAC
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,553,070
+$191,762 QoQ
Shares Held
646,743
+0.4% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 87 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. DMAC ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in DMAC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,553,070 | 646,743 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $4,361,308 | 644,211 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,997,057 | 627,771 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,274,125 | 476,583 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $982,597 | 251,948 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $322,259 | 85,029 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $461,707 | 85,029 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $287,974 | 68,729 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $202,750 | 68,729 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $184,562 | 66,629 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $189,226 | 66,629 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $171,902 | 66,629 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $287,837 | 66,629 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $101,942 | 66,629 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $105,280 | 66,629 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $82,619 | 66,629 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $134,590 | 66,629 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $166,572 | 66,629 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $222,744 | 59,717 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $159,265 | 39,717 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $134,465 | 30,217 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||